HIV treatment adherence and sexual functioning

AIDS and Behavior

Volumn 12, Issue 1, 2008, Pages 78-85

  Miguez Burbano, Maria Jose ^a   Espinoza, Luis ^a   Lewis, John E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; AIDS; BMI; HAART; HIV; Sexual dysfunction

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BODY IMAGE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONFIDENCE INTERVAL; DEPRESSION; DRUG EFFICACY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; MEDICAL INFORMATION; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; SELF REPORT; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SIDE EFFECT; SOCIAL LIFE; VIRUS LOAD;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 38449100008     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-006-9197-0     Document Type: Article

References (48)

1. Ammassari, A., Trotta, M., Murri, R., Castelli, F., Narciso, P., & Noto, P., et al. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31, S123-S127.
2. Aikens, J. E., Nease, D. E., Jr., Nau, D. P., Klinkman, M. S., & Schwenk, T. L. (2005). Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Annals of Family Medicine, 3, 23-30.
3. Badawi, A. F., Cavalieri, E. L., & Rogan, E. G. (2001). Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism, 50, 1001-1003.
4. Chesney, M. (2003). Adherence to HAART regimens. AIDS Patient Care STDs, 17, 169-177.
5. Colebunders, R., Moerman, F., & Noestlinger, C. (2006). Unexpected improvement of sexual dysfunction during atazanavir therapy. AIDS, 20(8), 1209-1210.
6. Collier, A. C., Coombs, R. W., Schoenfeld, D. A., Bassett, R. L., Timpone, J., & Baruch, A., et al. (1996). Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine. New England Journal of Medicine, 334, 1011-1017.
7. Collazos, J., Martinez, E., Mayo, J., & Ibarra, S. (2002). Sexual hormones in HIV-infected patients: The influence of antiretroviral therapy. AIDS, 16, 934-937.
8. Collins, E., Wagner, C., & Walmsley, S. (2000). Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Readers, 10, 546-550.
9. Cove, J., & Petrak, J. (2004). Factors associated with sexual problems in HIV-positive gay men. International Journal of STD and AIDS, 15, 732-736.
10. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment. Archives of Internal Medicine, 160, 2101-2107.
11. Dinsmore, W. (2004). Treatment of erectile dysfunction. International Journal of STD and AIDS, 15, 215-221.
12. Fleming M. (2000). Screening and Brief Intervention in Primary Care Settings. Available at: http://www.niaaa.nih.gov/publications/arh28-2/57-62.htm.
13. Goldstein, I. (2000). The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. American Journal Cardiology, 86, 41f-45f.
14. Gordillo, V., Amo, J. D., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
15. Guaraldi, G., Murri, R., Orlando, G., Orlandi, E., Sterrantino, G., Borderi, M., & Grosso, C., et al. (2003). Morphologic alterations in HIV-infected people with lipodystrophy are associated with good adherence to HAART. HIV Clinical Trials, 4, 99-106.
16. Halkitis, P. N. (2002). HIV treatment in the 21st century: The reality of adherence. Psychology AIDS, 31, 1-2.
17. Hammer, S. M., Kathleen, E. S., Hughes, M. D., Grimes, J. M., & Demeter, L. M., et al. (1997). A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4+ cell counts of 200 per cubic millimeter or less. New England Journal of Medicine, 337, 725-733.
18. Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., & Beall, G. N., et al. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaboration Treatment Group. AIDS, 13, 1099-1107.
19. Horne, R., Buick, D., Fisher, M., Leake, H., Cooper, V., & Weinman, J. (2004). Doubts about necessity and concerns about adverse effects: Identifying the types of beliefs that are associated with non-adherence to HAART. International Journal of STD and AIDS, 15, 38-44.
20. Ippolito, G., Galati, V., Serraino, D., & Girardi, E. (2001). The changing picture of the HIV/AIDS epidemic. Ann NY Acad Sci, 946, 1-12.
21. Katon, W. J. (2003). Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry, 54, 216-226.
22. Kim, A. A., Kent, C. K., & Klausner, J. D. (2002). Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000-2001. AIDS, 16, 1425-1428.
23. Klitzman, R. L., Kirshenbaum, S. B., Dodge, B., Remien, R. H., Ehrhardt, A. A., & Johnson, M. O., et al. (2004). NIMH Healthy Living Trial Group. Intricacies and inter-relationships between HIV disclosure and HAART: A qualitative study. AIDS Care, 16, 628-640.
24. Lallemand, F., Salhi, Y., Linard, F., Giami, A., & Rozenbaum, W. (2002). Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. Journal of Acquired Immune Deficiency Syndromes, 30, 187-190.
25. Lamba, H., Goldmeier, D., Mackie, N. E., & Scullard, G. (2004). Antiretroviral therapy is associated with sexual dysfunction and with increased serum oestradiol levels in men. International Journal of STD and AIDS, 15, 234-237.
26. Loh, C., Leckband, S. G., Meyer, J. M., & Turner, E. (2004). Risperidone-induced retrograde ejaculation: Case report and review of the literature. International Clinical Psychopharmacology, 19, 111-112.
27. Low-Beer, S., Yip, B., O'Shaughnessy, M. V., Hogg, R. S., & Montaner, J. S. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndromes, 23, 360-361.
28. Mehta, S., Moore, R. D., & Graham, N. (1997). Potential factors affecting adherence with HIV therapy. AIDS, 11, 1665-1670.
29. Moatti, J. P., & Spire, B. (2003). Economic and socio-behavioral issues related to highly active antiretroviral therapies for HIV infection: the contribution of social science research. MS-Medecine Sciences, 19(8-9), 878-884.
30. Monforte, A., Lepri, A., Rezza, G., Pezzotti, P., Antinori, A., & Phillips, A. N., et al. (2000). Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. AIDS, 14(5), 499-507.
31. Nurnberg, H. G. (2001). Managing treatment-emergent sexual dysfunction associated with serotonergic antidepressants: before and after sildenafil. Journal of Psychiatry Practice, 7, 92-108.
32. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., & Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med, 133, 21-30.
33. Perkins, D. O. (2002). Predictors of non-compliance in patients with schizophrenia. Journal of Clinical Psychiatry, 63, 1121-1128.
34. Persson, A. G. (2003). New-fill and Humour: Dealing with body shape change. National Centre in HIV Social Research. The University of New South Wales. Paper presented at the 15th Annual Conference of the Australasian Society for HIV Medicine: Cairns.
35. Power, C., Selnes, O. A., Grim, J. A., & McArthur, J. C. (1995). HIV dementia scale: A rapid screening test. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology, 8, 273-278.
36. Power, R., Tate, H. L., McGill, S. M., & Taylor, C. (2003). A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sexually Transmitted Infections, 79, 137-141.
37. Rodriguez-Rosado, R., Jimenez-Nacher, I., Soriano, V., Anton, P., & Gonzalez-Lahoz, J. (1998). Virological failure and adherence to antiretroviral therapy in HIV-infected patients. AIDS, 12, 1112-1113.
38. Saunders, J., Aasland, O., & Babor, T. (1993). Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption. Addiction, 88, 791-804.
39. Schrooten, W., Colebunders, R., Youle, M., Molenberghs, G., Dedes, N., & Koitz, G., et al. (2001). Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS, 15, 1019-1023.
40. Sheon, N., & Crosby, M. G. (2004). Ambivalent tales of HIV disclosure in San Francisco. Society of Science Medicine, 58(11), 2105-2118.
41. Solomon, H., Man, J., Gill, J., & Jackson, G. (2002). Viagra on the internet: Unsafe sexual practice. International Journal of Clinical Practice, 56, 403-404.
42. Steer, R. A., Cavalieri, T. A., Leonard, D. M., & Beck, A. T. (1999). Use of the Beck depression inventory for primary care to screen for major depression disorders. Gen Hosp Psychiatry, 21, 106-111.
43. Tindall, B., Forde, S., Goldstein, D., Ross, M. W., & Cooper, D. A. (1994). Sexual dysfunction in advanced HIV disease. AIDS Care, 6, 105-107.
44. Thompson, M., Gold, M., & Sathasivam, K. (2000). Adherence and relationship to antiretroviral efficacy in the HEART (NZT4006) study [abstract MoPpD1129]. In: Program and abstracts of the 13th International Conference on AIDS (Durban, South Africa) (172 p). Stockholm: International AIDS Society.
45. Trotta, M. P., Ammassari, A., Cozzi-Lepri, A., Zaccarelli, M., Castelli, F., & Narciso, P., et al. (2003). Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens. AIDS, 17(7), 1099-9102.
46. Tsasis, P. (2001). Adherence assessment to highly active antiretroviral therapy. AIDS Patient Care STDs, 15, 109-115.
47. von Giesen, H. J., Haslinger, B. A., Rohe, S., Koller, H., & Arendt, G. (2005). HIV dementia scale and psychomotor slowing-the best methods in screening for neuro-AIDS. Journal of Neuropsychiatry & Clinical Neurosciences, 17(2), 185-191.
48. Wilks, S. D. (2003). Is sildenafil effective for antidepressant-related sexual dysfunction?-Patient Oriented Evidence That Matters: Practice recommendations from key studies [online] Available at: http://www.findarticles. com/p/articles/mi_m0689/is_4_52/ai_100171274.